Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray (Protein Chips), Reagents (Immunoassay), Services (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Global Forecast to 2029
The global proteomics market is estimated to reach USD 60.5 billion by 2029 from USD 33.6 billion in 2024, at a CAGR of 12.4% during the forecast period of 2024 to 2029.
“The spectroscopy segment holds dominant share in the proteomics market.”
Based on the technology, the proteomics market is divided into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment accounted for the largest share of 48.8% owing to factors such as technique is increased use in protein analysis, providing information about protein structure, size, shape, secondary or tertiary conformation, quantification, and interaction with other molecules, such as ligands, solutes, or other proteins.
“The immunoassay reagent dominated the reagent segments.”
Based on reagent, the proteomics market is segmented into, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents accounted for the largest share of 26.5% of the reagent segment however spectroscopy reagent is anticipated to grow at significant CAGR during the forecast period. Factors like growing use of mass spectrometry-based techniques, development of high-throughput mass spectrometry techniques and increasing interest in personalized medicine are likely to drive the segmental growth.
“Biopharmaceutical companies segment is likely to grow at significant CAGR during the forecast period”
Based on end user, the proteomics market is segmented into hospitals, clinical laboratories, biopharmaceutical companies, academic & research institutes, and other end users. The biopharmaceutical companies segment accounted for the largest share of 39.1% of the proteomics market owing to rising focus of pharma giants on core activities like increasing R&D for the discovery and development of new molecules, identification of biomarkers and personalized medicine.
“Asia Pacific region estimated to show fastest growth rate.”
Geographically, the proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the proteomics market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as growing fields of proteomics and genomics research in conjunction with an increase in funding toward research studies. Rising investment by biopharmaceutical companies, growing research activity in the area of mAb-based therapeutics are likely to drive market expansion in the region.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the proteomics market. It aims at estimating the size and future growth potential of the market across different segments such as technology, reagent, service, software, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“The spectroscopy segment holds dominant share in the proteomics market.”
Based on the technology, the proteomics market is divided into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment accounted for the largest share of 48.8% owing to factors such as technique is increased use in protein analysis, providing information about protein structure, size, shape, secondary or tertiary conformation, quantification, and interaction with other molecules, such as ligands, solutes, or other proteins.
“The immunoassay reagent dominated the reagent segments.”
Based on reagent, the proteomics market is segmented into, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents accounted for the largest share of 26.5% of the reagent segment however spectroscopy reagent is anticipated to grow at significant CAGR during the forecast period. Factors like growing use of mass spectrometry-based techniques, development of high-throughput mass spectrometry techniques and increasing interest in personalized medicine are likely to drive the segmental growth.
“Biopharmaceutical companies segment is likely to grow at significant CAGR during the forecast period”
Based on end user, the proteomics market is segmented into hospitals, clinical laboratories, biopharmaceutical companies, academic & research institutes, and other end users. The biopharmaceutical companies segment accounted for the largest share of 39.1% of the proteomics market owing to rising focus of pharma giants on core activities like increasing R&D for the discovery and development of new molecules, identification of biomarkers and personalized medicine.
“Asia Pacific region estimated to show fastest growth rate.”
Geographically, the proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the proteomics market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as growing fields of proteomics and genomics research in conjunction with an increase in funding toward research studies. Rising investment by biopharmaceutical companies, growing research activity in the area of mAb-based therapeutics are likely to drive market expansion in the region.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70%, and Demand Side - 30%
- By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%
- Thermo fisher Scientific Inc (US)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Waters Corporation (US)
- Bio-Rad Laboratories, Inc. (US)
- Bruker Corporation (US)
- Revvity (US)
- Shimadzu Corporation (Japan)
- Illumina Inc (US)
- Promega Corporation (US)
- Eurofins Scientific (Luxembourg)
- Qiagen (Netherlands)
- Charles River Laboratories (US)
- Protagene (Germany)
- Creative Proteomics (US)
- Horiba (Japan)
- Sengenics Corporation LLC (US)
- Labvantage-Biomax GmbH (Germany)
- Cell Signaling Technology, Inc. (US)
- FIOS Genomics (UK)
- Azenta Life Sciences (US)
- Medgenome (India)
- Biognosys AG (Switzerland)
- Macrogen Inc (South Korea)
This report provides a detailed picture of the proteomics market. It aims at estimating the size and future growth potential of the market across different segments such as technology, reagent, service, software, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key Drivers (Growing demand for personalized medicines for clinical practices, Increased investments in proteomics research and development, Rising Application in Drug Discovery and Development and Government and Private Funding) restraints (High costs of proteomics instruments and technologies, Lack of standardization in proteomics techniques) opportunities (Advancements in Bioinformatics, Advancements in Single-Cell Proteomics and Collaborations and Partnerships) and challenges (Lack of data management/handling in proteomics research) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the proteomics market.
- Market Development: Comprehensive information about lucrative markets the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the proteomics market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and products offerings of leading players like Thermo fisher Scientific Inc (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Waters Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Revvity (US), Shimadzu Corporation (Japan), Illumina Inc (US), Promega Corporation (US), Eurofins (Luxembourg), Qiagen (Netherlands), Charles River Laboratories (US), Protagene (Germany), Creative Proteomics (US), Horiba (Japan), Sengenics Corporation LLC (US), Labvantage-Biomax GmbH (Germany), Cell Signaling Technology, Inc. (US), FIOS Genomics (UK), Azenta Life Sciences (US), Medgenome (India), Biognosys AG (Switzerland) and Macrogen Inc (South Korea).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS CONSIDERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Objectives of primary research
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
2.2.2 MNM REPOSITORY ANALYSIS
2.2.3 PRIMARY INTERVIEWS
2.2.4 SECONDARY RESEARCH
2.2.5 INSIGHTS FROM PRIMARIES
2.2.6 TOP-DOWN APPROACH
2.2.7 MARKET GROWTH RATE PROJECTIONS
2.3 DATA TRIANGULATION
2.4 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PROTEOMICS MARKET OVERVIEW
4.2 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2023
4.3 SPECTROSCOPY INSTRUMENTATION TECHNOLOGY MARKET, BY TYPE, 2024 VS. 2029
4.4 PROTEOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing demand for personalized medicines in clinical practices
5.2.1.2 High investments in pharmaceutical R&D
5.2.1.3 Rising applications in drug discovery and development
5.2.1.4 Increased private and government funding
5.2.2 RESTRAINTS
5.2.2.1 High costs of proteomics instruments and technologies
5.2.2.2 Lack of standardization
5.2.3 OPPORTUNITIES
5.2.3.1 Advancements in bioinformatics
5.2.3.2 Developments in single-cell proteomics research
5.2.3.3 Increasing number of collaborations and strategic partnerships
5.2.4 CHALLENGES
5.2.4.1 Lack of data management and handling
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Mass spectrometry
5.4.1.1.1 Intact or top-down protein analysis
5.4.1.2 Chromatography
5.4.1.3 Protein microarrays
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Transcriptomics
5.4.2.2 Metabolomics
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Single-cell proteomics
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE SELLING PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021–2023
5.5.2 AVERAGE SELLING PRICE TREND OF PROTEOMICS INSTRUMENTS,
BY REGION, 2023
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
5.8.1 PROTEOMICS PRODUCT AND SERVICE PROVIDERS
5.8.2 END USERS
5.8.3 REGULATORY BODIES
5.9 PATENT ANALYSIS
5.9.1 METHODOLOGY
5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE,
2013–2024
5.9.3 INNOVATION AND PATENT APPLICATION
5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF APPLICATIONS
5.9.5 TOP 10 PATENT OWNERS
5.9.6 KEY PATENTS IN PROTEOMICS MARKET
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)
5.10.2 EXPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)
5.10.3 IMPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781)
5.10.4 EXPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781)
5.11 KEY CONFERENCES AND EVENTS, 2024–2025
5.12 REGULATORY LANDSCAPE
5.12.1 REGULATORY SCENARIO
5.12.1.1 North America
5.12.1.2 Europe
5.12.1.3 Asia Pacific
5.12.1.4 Rest of the world
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 INVESTMENT AND FUNDING SCENARIO
5.14 PORTER’S FIVE FORCES ANALYSIS
5.14.1 THREAT OF NEW ENTRANTS
5.14.2 THREAT OF SUBSTITUTES
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 BARGAINING POWER OF SUPPLIERS
5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
5.15.2 KEY BUYING CRITERIA
5.16 IMPACT OF AI/GEN AI ON PROTEOMICS MARKET
6 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY
6.1 INTRODUCTION
6.2 SPECTROSCOPY
6.2.1 MASS SPECTROMETRY
6.2.1.1 High specificity and technological advancements to propel segment growth
6.2.2 NMR SPECTROSCOPY
6.2.2.1 Accurate evaluation of physical, chemical, electronic, and structural information of proteins to aid segment growth
6.2.3 CD SPECTROSCOPY
6.2.3.1 Non-destructive and non-invasive techniques to examine changes in secondary protein structures
6.3 CHROMATOGRAPHY
6.3.1 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
6.3.1.1 High resolution, sensitivity, and reproducibility to spur segment growth
6.3.2 ION CHROMATOGRAPHY
6.3.2.1 High resolving power, simplicity, and controllability to separate and purify proteins
6.3.3 AFFINITY CHROMATOGRAPHY
6.3.3.1 High specificity for target proteins and easy identification of novel protein interactions to drive segment
6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
6.3.4.1 Ability to separate complex protein mixtures with high efficiency and speed to fuel segment growth
6.4 ELECTROPHORESIS
6.4.1 GEL ELECTROPHORESIS
6.4.1.1 Increasing demand for proteomics research and personalized medicine to boost segment growth
6.4.2 CAPILLARY ELECTROPHORESIS
6.4.2.1 Low diffusion coefficients of biomolecules and easy elimination of sample carryover between measurements to drive market
6.5 PROTEIN MICROARRAYS
6.5.1 BIOCHIPS
6.5.1.1 Lab-on-chips
6.5.1.1.1 Rising focus on microfabrication and nanotechnology development to aid segment growth
6.5.1.2 Protein chips
6.5.1.2.1 Competitive advantage over conventional protein analysis tools to propel segment growth
6.5.2 MICROARRAY INSTRUMENTS
6.5.2.1 Integrated systems
6.5.2.1.1 Integrated systems to enable high-throughput and reproducible analysis of proteins
6.5.2.2 Microarray scanners
6.5.2.2.1 Cost-effective and high-quality analysis to propel segment growth
6.5.2.3 Arrayers
6.5.2.3.1 Technological advancements to drive adoption of arrayers in large-scale projects
6.6 X-RAY CRYSTALLOGRAPHY
6.6.1 RISING NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO AUGMENT MARKET GROWTH
6.7 SURFACE PLASMON RESONANCE
6.7.1 INCREASING ABILITY TO BIND AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET GROWTH
6.8 PROTEIN FRACTIONATION
6.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF PROTEINS IN COMPLEX MIXTURES
6.9 OTHER INSTRUMENTATION TECHNOLOGIES
7 PROTEOMICS MARKET, BY REAGENT
7.1 INTRODUCTION
7.2 IMMUNOASSAY REAGENTS
7.2.1 NEED FOR RELIABLE, SPECIFIC, AND FAST DISEASE DETECTION AT EARLY STAGES TO FAVOR MARKET GROWTH
7.3 SPECTROSCOPY REAGENTS
7.3.1 INCREASED ADOPTION OF HIGH-THROUGHPUT MASS SPECTROSCOPY-BASED TECHNIQUES TO AID MARKET GROWTH
7.4 CHROMATOGRAPHY REAGENTS
7.4.1 BETTER ACCURACY AND LOWER DETECTION LIMITS TO FACILITATE SEGMENT GROWTH
7.5 PROTEIN MICROARRAY REAGENTS
7.5.1 DEVELOPMENT OF NOVEL AND ADVANCED PROTEIN ANALYSIS REAGENTS TO PROPEL MARKET GROWTH
7.6 X-RAY CRYSTALLOGRAPHY REAGENTS
7.6.1 EMERGENCE OF NEW TARGETS FOR DRUG DISCOVERY AND HIGH R&D INVESTMENTS TO SUPPORT MARKET GROWTH
7.7 ELECTROPHORESIS REAGENTS
7.7.1 INCREASING DEMAND FOR 2D ELECTROPHORESIS TO AUGMENT MARKET GROWTH
7.8 PROTEIN FRACTIONATION REAGENTS
7.8.1 RISING NEED FOR PROTEIN FRACTIONATION TECHNIQUES TO AUGMENT MARKET GROWTH
7.9 OTHER REAGENTS
8 PROTEOMICS MARKET, BY SERVICE
8.1 INTRODUCTION
8.2 CORE PROTEOMICS SERVICES
8.2.1 PROTEIN IDENTIFICATION SERVICES
8.2.1.1 Rising need for protein identification and molecular weight analysis to boost market growth
8.2.2 QUANTITATIVE PROTEOMICS SERVICES
8.2.2.1 Rapid and low-cost alternatives to help understand global protein expression and modifications
8.2.3 PROTEIN CHARACTERIZATION SERVICES
8.2.3.1 Characterization studies to help study complex protein structure, drug development, and PTMs
8.2.4 PROTEIN PURIFICATION SERVICES
8.2.4.1 Protein purification to maximize yield and purity of protein of interest
8.2.5 PROTEIN SEPARATION SERVICES
8.2.5.1 Technological advancements and use in downstream applications to augment segment growth
8.2.6 PROTEIN SEQUENCING SERVICES
8.2.6.1 Identification and characterization of PTMs to favor protein sequencing and research
8.2.7 CUSTOM ASSAY SERVICES
8.2.7.1 Custom assays to improve validation or consistency of protein analysis procedures
8.3 BIOINFORMATICS SERVICES
8.3.1 LESSER ANALYSIS TIME AND FAVORABLE GOVERNMENT INITIATIVES TO SPUR MARKET GROWTH
9 PROTEOMICS MARKET, BY SOFTWARE
9.1 INTRODUCTION
9.1.1 BIOINFORMATICS TOOLS
9.1.1.1 Need for data management and advancements in bioinformatics to augment market growth
9.1.2 BIOINFORMATICS DATABASES
9.1.2.1 Need to store proteomics data and integrate other omics databases to drive market
10 PROTEOMICS MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 CLINICAL DIAGNOSTICS
10.2.1 CANCER
10.2.1.1 Rising prevalence of cancer to propel market growth
10.2.2 INFECTIOUS DISEASES
10.2.2.1 Technological advancements and need for effective disease diagnosis to support market growth
10.2.3 DIABETES
10.2.3.1 Need for advanced diagnostic technologies and high diabetes prevalence to aid market growth
10.2.4 NEUROLOGICAL DISORDERS
10.2.4.1 Growing target patient population and increasing research grants to fuel market growth
10.2.5 AUTOIMMUNE DISEASES
10.2.5.1 Increasing patient population and growing focus on immunology-based research to propel market growth
10.2.6 CARDIOVASCULAR DISEASES
10.2.6.1 High burden of cardiovascular diseases to spur adoption of reliable diagnostic tools
10.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS
10.3 DRUG DISCOVERY & DEVELOPMENT
10.3.1 TARGET DISCOVERY
10.3.1.1 Increased demand for personalized medicine to support segment growth
10.3.2 LEAD IDENTIFICATION
10.3.2.1 Lead identification to be essential in drug discovery and characterization
10.3.3 LEAD OPTIMIZATION
10.3.3.1 Need for optimizing drug efficacy and safety to spur segment growth
10.3.4 PRECLINICAL STUDIES
10.3.4.1 Integration of proteomics in preclinical studies to refine drug safety and efficacy
10.4 OTHER APPLICATIONS
11 PROTEOMICS MARKET, BY END USER
11.1 INTRODUCTION
11.2 BIOPHARMACEUTICAL COMPANIES
11.2.1 LOW OPERATING COSTS AND RAPID DRUG ANALYSIS TO DRIVE MARKET
11.3 ACADEMIC AND RESEARCH INSTITUTES
11.3.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINE TO BOOST MARKET GROWTH
11.4 HOSPITALS
11.4.1 GROWING PREVALENCE OF IMMUNODEFICIENCY DISEASES AND SERUM PROTEIN DISORDERS TO BOOST MARKET GROWTH
11.5 CLINICAL LABORATORIES
11.5.1 INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO SUPPORT MARKET GROWTH
11.6 OTHER END USERS
12 PROTEOMICS MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 US to dominate North American proteomics market during study period
12.2.3 CANADA
12.2.3.1 Favorable government initiatives and high incidence of cancer to support market growth
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Well-established pharmaceutical industry and increased government funding to augment market growth
12.3.3 UK
12.3.3.1 Developed life science industry and increased academia-industry partnerships to augment market growth
12.3.4 FRANCE
12.3.4.1 High investments in life science R&D and increased demand for personalized therapeutics to aid market growth
12.3.5 SWITZERLAND
12.3.5.1 Well-established pharmaceutical and biotechnology industry and increased investments in life science R&D to drive market
12.3.6 ITALY
12.3.6.1 High private and public R&D funding and favorable government initiatives to favor market growth
12.3.7 SPAIN
12.3.7.1 Well-established network of research centers, universities, and hospitals to aid market growth
12.3.8 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Rising government R&D investments and increasing focus on healthcare product manufacturing to fuel market growth
12.4.3 JAPAN
12.4.3.1 Large geriatric population and strong pharmaceutical research base to drive market
12.4.4 INDIA
12.4.4.1 Increasing focus on proteomics and genomic research to support market growth
12.4.5 SOUTH KOREA
12.4.5.1 Developed medical tourism and advanced healthcare infrastructure to propel market growth
12.4.6 AUSTRALIA
12.4.6.1 Favorable government initiatives and high R&D investments to favor market growth
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Increasing contract research and manufacturing activities to drive market
12.5.3 MEXICO
12.5.3.1 Strong pharmaceutical industry and increased government support to augment market growth
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
12.6.2 GCC COUNTRIES
12.6.2.1 Saudi Arabia
12.6.2.1.1 Increasing government healthcare investments and developing pharmaceuticals industry to boost market growth
12.6.2.2 UAE
12.6.2.2.1 High R&D expenditure and developed health infrastructure to drive market
12.6.2.3 Rest of GCC Countries
12.6.3 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 FAVORABLE GOVERNMENT INITIATIVES AND ADVANCEMENTS IN PERSONALIZED MEDICINES TO PROPEL MARKET GROWTH
12.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET
13.3 REVENUE ANALYSIS, 2021–2023
13.4 MARKET SHARE ANALYSIS, 2023
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Instrumentation technology footprint
13.5.5.3 Reagent footprint
13.5.5.4 Service footprint
13.5.5.5 Software footprint
13.5.5.6 Region footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 THERMO FISHER SCIENTIFIC INC.
14.1.1.1 Business overview
14.1.1.2 Products/Services/Solutions offered
14.1.2 RECENT DEVELOPMENTS
14.1.2.1 Product launches
14.1.2.2 Deals
14.1.2.3 MnM view
14.1.2.3.1 Key strengths
14.1.2.3.2 Strategic choices
14.1.2.3.3 Weaknesses and competitive threats
14.1.3 AGILENT TECHNOLOGIES, INC.
14.1.3.1 Business overview
14.1.3.2 Products/Services/Solutions offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.3.2 Deals
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 MERCK KGAA
14.1.4.1 Business overview
14.1.4.2 Products/Services/Solutions offered
14.1.4.3 MnM view
14.1.4.3.1 Key strengths
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses and competitive threats
14.1.5 DANAHER CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products/Services/Solutions offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.4 MnM view
14.1.5.4.1 Key strengths
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 SHIMADZU CORPORATION
14.1.6.1 Business overview
14.1.6.2 Products/Services/Solutions offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches
14.1.6.3.2 Expansions
14.1.6.4 MnM view
14.1.6.4.1 Key strengths
14.1.6.4.2 Strategic choices
14.1.6.4.3 Weaknesses and competitive threats
14.1.7 WATERS CORPORATION
14.1.7.1 Business overview
14.1.7.2 Products/Services/Solutions offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.8 BIO-RAD LABORATORIES, INC.
14.1.8.1 Business overview
14.1.8.2 Products/Services/Solutions offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.9 BRUKER
14.1.9.1 Business overview
14.1.9.2 Products/Services/Solutions offered
14.1.9.3 Recent developments
14.1.9.3.1 Product launches
14.1.9.3.2 Deals
14.1.10 REVVITY
14.1.10.1 Business overview
14.1.10.2 Products/Services/Solutions offered
14.1.10.3 Recent developments
14.1.10.3.1 Deals
14.1.11 ILLUMINA, INC.
14.1.11.1 Business overview
14.1.11.2 Products/Services/Solutions offered
14.1.11.3 Recent developments
14.1.11.3.1 Deals
14.1.12 PROMEGA CORPORATION
14.1.12.1 Business overview
14.1.12.2 Products/Services/Solutions offered
14.1.13 EUROFINS SCIENTIFIC
14.1.13.1 Business overview
14.1.13.2 Products/Services/Solutions offered
14.1.13.3 Recent developments
14.1.13.3.1 Deals
14.1.14 QIAGEN
14.1.14.1 Business overview
14.1.14.2 Products/Services/Solutions offered
14.1.14.3 Recent developments
14.1.14.3.1 Product launches
14.1.14.3.2 Deals
14.1.15 CHARLES RIVER LABORATORIES
14.1.15.1 Business overview
14.1.15.2 Products/Services/Solutions offered
14.1.15.3 Recent developments
14.1.15.3.1 Product launches
14.1.15.3.2 Deals
14.1.16 PROTAGENE
14.1.16.1 Business overview
14.1.16.2 Products/Services/Solutions offered
14.2 OTHER PLAYERS
14.2.1 CREATIVE PROTEOMICS, US
14.2.2 HORIBA JAPAN LTD.
14.2.3 SENGENICS CORPORATION LLC
14.2.4 LABVANTAGE-BIOMAX GMBH
14.2.5 FIOS GENOMICS
14.2.6 AZENTA US, INC.
14.2.7 MEDGENOME
14.2.8 BIOGNOSYS AG
14.2.9 MACROGEN, INC.
14.2.10 CELL SIGNALING TECHNOLOGY, INC.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
TABLE 1 PROTEOMICS MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 3 PROTEOMICS MARKET: RISK ANALYSIS
TABLE 4 INDICATIVE PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021–2023 (USD)
TABLE 5 PROTEOMICS PRODUCT AND SERVICE PROVIDERS: ROLE IN ECOSYSTEM
TABLE 6 END USERS: ROLE IN ECOSYSTEM
TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, JANUARY 2013–AUGUST 2024
TABLE 9 PROTEOMICS MARKET: TOP 10 PATENT OWNERS, 2013–2023
TABLE 10 KEY PATENTS IN PROTEOMICS MARKET, 2021–2024
TABLE 11 IMPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019–2023 (TON)
TABLE 12 EXPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019–2023 (TON)
TABLE 13 IMPORT VOLUME FOR MASS SPECTROMETERS (HS CODE: 902781),
2022–2023 (USD)
TABLE 14 EXPORT VOLUME FOR MASS SPECTROMETERS (HS CODE-902781),
2022–2023 (USD)
TABLE 15 PROTEOMICS MARKET: LIST OF KEY CONFERENCES AND EVENTS,
JANUARY 2024–DECEMBER 2025
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 PROTEOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES
TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE END USERS
TABLE 22 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 23 PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 24 PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION,
2022–2029 (USD MILLION)
TABLE 25 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 27 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 28 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 29 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 30 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 MASS SPECTROMETRY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 32 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 33 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 34 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 35 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 36 MIDDLE EAST: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 37 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 38 NMR SPECTROSCOPY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 39 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 40 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 41 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 42 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 43 MIDDLE EAST: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 44 GCC COUNTRIES: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 45 CD SPECTROSCOPY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 47 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 49 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 50 MIDDLE EAST: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 51 GCC COUNTRIES: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 52 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2022–2029 (USD MILLION)
TABLE 53 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION,
2022–2029 (USD MILLION)
TABLE 54 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 56 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 61 NORTH AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 EUROPE: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 ASIA PACIFIC: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 LATIN AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 MIDDLE EAST: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 GCC COUNTRIES: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ION CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 69 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 70 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 71 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 72 MIDDLE EAST: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 73 GCC COUNTRIES: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 74 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 75 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 76 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 77 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 78 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 79 MIDDLE EAST: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 80 GCC COUNTRIES: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 81 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 MIDDLE EAST: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 GCC COUNTRIES: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2022–2029 (USD MILLION)
TABLE 89 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION,
2022–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 92 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 GEL ELECTROPHORESIS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 98 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 99 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 100 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 101 MIDDLE EAST: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 102 GCC COUNTRIES: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 103 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 104 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 105 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 106 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 107 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 108 MIDDLE EAST: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 109 GCC COUNTRIES: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 110 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2022–2029 (USD MILLION)
TABLE 111 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION,
2022–2029 (USD MILLION)
TABLE 112 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 119 BIOCHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 LATIN AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 MIDDLE EAST: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 GCC COUNTRIES: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 LAB-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 127 NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 128 EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 131 MIDDLE EAST: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 GCC COUNTRIES: LAB-ON-CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 133 PROTEIN CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 134 NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 135 EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 138 MIDDLE EAST: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 GCC COUNTRIES: PROTEIN CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 140 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 141 MICROARRAY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 142 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 143 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 144 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 145 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 146 MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 147 GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 148 INTEGRATED SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 150 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 151 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 152 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 153 MIDDLE EAST: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 154 GCC COUNTRIES: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 155 MICROARRAY SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 156 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 157 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 158 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 159 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 160 MIDDLE EAST: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 161 GCC COUNTRIES: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 162 ARRAYERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 163 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 MIDDLE EAST: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 GCC COUNTRIES: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION,
2022–2029 (USD MILLION)
TABLE 170 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 172 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION,
2022–2029 (USD MILLION)
TABLE 177 NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 MIDDLE EAST: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 GCC COUNTRIES: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION,
2022–2029 (USD MILLION)
TABLE 184 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES,
BY REGION, 2022–2029 (USD MILLION)
TABLE 191 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 EUROPE: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 193 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 PROTEOMICS MARKETS, BY REAGENT, 2022–2029 (USD MILLION)
TABLE 198 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 199 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 200 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 206 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 207 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 213 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 214 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 215 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 220 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 221 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 222 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 227 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 229 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 234 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 236 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 241 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 244 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 PROTEOMICS MARKET FOR OTHER REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 248 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 250 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 251 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
TABLE 255 CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 256 CORE PROTEOMICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 257 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 258 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 259 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 260 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 261 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 262 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 263 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 264 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 265 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 266 ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 267 LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 MIDDLE EAST: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 269 GCC COUNTRIES: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 271 NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 272 EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 273 ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 275 MIDDLE EAST: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 276 GCC COUNTRIES: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 277 PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 278 NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 279 EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 280 ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281 LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2022–2029 (USD MILLION)
TABLE 282 MIDDLE EAST: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 283 GCC COUNTRIES: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 284 PROTEIN PURIFICATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 285 NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 286 EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 287 ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 288 LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 289 MIDDLE EAST: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 290 GCC COUNTRIES: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 291 PROTEIN SEPARATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 292 NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 293 EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 294 ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 295 LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 296 MIDDLE EAST: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 297 GCC COUNTRIES: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 298 PROTEIN SEQUENCING SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 299 NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 300 EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 301 ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 302 LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 303 MIDDLE EAST: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 304 GCC COUNTRIES: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 305 CUSTOM ASSAY SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 306 NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 307 EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 308 ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 309 LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 310 MIDDLE EAST: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 311 GCC COUNTRIES: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 312 BIOINFORMATICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 313 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 314 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 315 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 316 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 317 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 318 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 319 PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
TABLE 320 PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION,
2022–2029 (USD MILLION)
TABLE 321 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 322 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 323 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 324 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 325 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 326 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 327 PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY REGION,
2022–2029 (USD MILLION)
TABLE 328 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 329 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 330 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 331 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 332 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 333 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 334 PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 335 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2022–2029 (USD MILLION)
TABLE 336 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION,
2022–2029 (USD MILLION)
TABLE 337 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 338 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS CONSIDERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Objectives of primary research
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
2.2.2 MNM REPOSITORY ANALYSIS
2.2.3 PRIMARY INTERVIEWS
2.2.4 SECONDARY RESEARCH
2.2.5 INSIGHTS FROM PRIMARIES
2.2.6 TOP-DOWN APPROACH
2.2.7 MARKET GROWTH RATE PROJECTIONS
2.3 DATA TRIANGULATION
2.4 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PROTEOMICS MARKET OVERVIEW
4.2 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2023
4.3 SPECTROSCOPY INSTRUMENTATION TECHNOLOGY MARKET, BY TYPE, 2024 VS. 2029
4.4 PROTEOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing demand for personalized medicines in clinical practices
5.2.1.2 High investments in pharmaceutical R&D
5.2.1.3 Rising applications in drug discovery and development
5.2.1.4 Increased private and government funding
5.2.2 RESTRAINTS
5.2.2.1 High costs of proteomics instruments and technologies
5.2.2.2 Lack of standardization
5.2.3 OPPORTUNITIES
5.2.3.1 Advancements in bioinformatics
5.2.3.2 Developments in single-cell proteomics research
5.2.3.3 Increasing number of collaborations and strategic partnerships
5.2.4 CHALLENGES
5.2.4.1 Lack of data management and handling
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Mass spectrometry
5.4.1.1.1 Intact or top-down protein analysis
5.4.1.2 Chromatography
5.4.1.3 Protein microarrays
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Transcriptomics
5.4.2.2 Metabolomics
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Single-cell proteomics
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE SELLING PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021–2023
5.5.2 AVERAGE SELLING PRICE TREND OF PROTEOMICS INSTRUMENTS,
BY REGION, 2023
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
5.8.1 PROTEOMICS PRODUCT AND SERVICE PROVIDERS
5.8.2 END USERS
5.8.3 REGULATORY BODIES
5.9 PATENT ANALYSIS
5.9.1 METHODOLOGY
5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE,
2013–2024
5.9.3 INNOVATION AND PATENT APPLICATION
5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF APPLICATIONS
5.9.5 TOP 10 PATENT OWNERS
5.9.6 KEY PATENTS IN PROTEOMICS MARKET
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)
5.10.2 EXPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)
5.10.3 IMPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781)
5.10.4 EXPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781)
5.11 KEY CONFERENCES AND EVENTS, 2024–2025
5.12 REGULATORY LANDSCAPE
5.12.1 REGULATORY SCENARIO
5.12.1.1 North America
5.12.1.2 Europe
5.12.1.3 Asia Pacific
5.12.1.4 Rest of the world
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 INVESTMENT AND FUNDING SCENARIO
5.14 PORTER’S FIVE FORCES ANALYSIS
5.14.1 THREAT OF NEW ENTRANTS
5.14.2 THREAT OF SUBSTITUTES
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 BARGAINING POWER OF SUPPLIERS
5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
5.15.2 KEY BUYING CRITERIA
5.16 IMPACT OF AI/GEN AI ON PROTEOMICS MARKET
6 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY
6.1 INTRODUCTION
6.2 SPECTROSCOPY
6.2.1 MASS SPECTROMETRY
6.2.1.1 High specificity and technological advancements to propel segment growth
6.2.2 NMR SPECTROSCOPY
6.2.2.1 Accurate evaluation of physical, chemical, electronic, and structural information of proteins to aid segment growth
6.2.3 CD SPECTROSCOPY
6.2.3.1 Non-destructive and non-invasive techniques to examine changes in secondary protein structures
6.3 CHROMATOGRAPHY
6.3.1 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
6.3.1.1 High resolution, sensitivity, and reproducibility to spur segment growth
6.3.2 ION CHROMATOGRAPHY
6.3.2.1 High resolving power, simplicity, and controllability to separate and purify proteins
6.3.3 AFFINITY CHROMATOGRAPHY
6.3.3.1 High specificity for target proteins and easy identification of novel protein interactions to drive segment
6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
6.3.4.1 Ability to separate complex protein mixtures with high efficiency and speed to fuel segment growth
6.4 ELECTROPHORESIS
6.4.1 GEL ELECTROPHORESIS
6.4.1.1 Increasing demand for proteomics research and personalized medicine to boost segment growth
6.4.2 CAPILLARY ELECTROPHORESIS
6.4.2.1 Low diffusion coefficients of biomolecules and easy elimination of sample carryover between measurements to drive market
6.5 PROTEIN MICROARRAYS
6.5.1 BIOCHIPS
6.5.1.1 Lab-on-chips
6.5.1.1.1 Rising focus on microfabrication and nanotechnology development to aid segment growth
6.5.1.2 Protein chips
6.5.1.2.1 Competitive advantage over conventional protein analysis tools to propel segment growth
6.5.2 MICROARRAY INSTRUMENTS
6.5.2.1 Integrated systems
6.5.2.1.1 Integrated systems to enable high-throughput and reproducible analysis of proteins
6.5.2.2 Microarray scanners
6.5.2.2.1 Cost-effective and high-quality analysis to propel segment growth
6.5.2.3 Arrayers
6.5.2.3.1 Technological advancements to drive adoption of arrayers in large-scale projects
6.6 X-RAY CRYSTALLOGRAPHY
6.6.1 RISING NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO AUGMENT MARKET GROWTH
6.7 SURFACE PLASMON RESONANCE
6.7.1 INCREASING ABILITY TO BIND AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET GROWTH
6.8 PROTEIN FRACTIONATION
6.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF PROTEINS IN COMPLEX MIXTURES
6.9 OTHER INSTRUMENTATION TECHNOLOGIES
7 PROTEOMICS MARKET, BY REAGENT
7.1 INTRODUCTION
7.2 IMMUNOASSAY REAGENTS
7.2.1 NEED FOR RELIABLE, SPECIFIC, AND FAST DISEASE DETECTION AT EARLY STAGES TO FAVOR MARKET GROWTH
7.3 SPECTROSCOPY REAGENTS
7.3.1 INCREASED ADOPTION OF HIGH-THROUGHPUT MASS SPECTROSCOPY-BASED TECHNIQUES TO AID MARKET GROWTH
7.4 CHROMATOGRAPHY REAGENTS
7.4.1 BETTER ACCURACY AND LOWER DETECTION LIMITS TO FACILITATE SEGMENT GROWTH
7.5 PROTEIN MICROARRAY REAGENTS
7.5.1 DEVELOPMENT OF NOVEL AND ADVANCED PROTEIN ANALYSIS REAGENTS TO PROPEL MARKET GROWTH
7.6 X-RAY CRYSTALLOGRAPHY REAGENTS
7.6.1 EMERGENCE OF NEW TARGETS FOR DRUG DISCOVERY AND HIGH R&D INVESTMENTS TO SUPPORT MARKET GROWTH
7.7 ELECTROPHORESIS REAGENTS
7.7.1 INCREASING DEMAND FOR 2D ELECTROPHORESIS TO AUGMENT MARKET GROWTH
7.8 PROTEIN FRACTIONATION REAGENTS
7.8.1 RISING NEED FOR PROTEIN FRACTIONATION TECHNIQUES TO AUGMENT MARKET GROWTH
7.9 OTHER REAGENTS
8 PROTEOMICS MARKET, BY SERVICE
8.1 INTRODUCTION
8.2 CORE PROTEOMICS SERVICES
8.2.1 PROTEIN IDENTIFICATION SERVICES
8.2.1.1 Rising need for protein identification and molecular weight analysis to boost market growth
8.2.2 QUANTITATIVE PROTEOMICS SERVICES
8.2.2.1 Rapid and low-cost alternatives to help understand global protein expression and modifications
8.2.3 PROTEIN CHARACTERIZATION SERVICES
8.2.3.1 Characterization studies to help study complex protein structure, drug development, and PTMs
8.2.4 PROTEIN PURIFICATION SERVICES
8.2.4.1 Protein purification to maximize yield and purity of protein of interest
8.2.5 PROTEIN SEPARATION SERVICES
8.2.5.1 Technological advancements and use in downstream applications to augment segment growth
8.2.6 PROTEIN SEQUENCING SERVICES
8.2.6.1 Identification and characterization of PTMs to favor protein sequencing and research
8.2.7 CUSTOM ASSAY SERVICES
8.2.7.1 Custom assays to improve validation or consistency of protein analysis procedures
8.3 BIOINFORMATICS SERVICES
8.3.1 LESSER ANALYSIS TIME AND FAVORABLE GOVERNMENT INITIATIVES TO SPUR MARKET GROWTH
9 PROTEOMICS MARKET, BY SOFTWARE
9.1 INTRODUCTION
9.1.1 BIOINFORMATICS TOOLS
9.1.1.1 Need for data management and advancements in bioinformatics to augment market growth
9.1.2 BIOINFORMATICS DATABASES
9.1.2.1 Need to store proteomics data and integrate other omics databases to drive market
10 PROTEOMICS MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 CLINICAL DIAGNOSTICS
10.2.1 CANCER
10.2.1.1 Rising prevalence of cancer to propel market growth
10.2.2 INFECTIOUS DISEASES
10.2.2.1 Technological advancements and need for effective disease diagnosis to support market growth
10.2.3 DIABETES
10.2.3.1 Need for advanced diagnostic technologies and high diabetes prevalence to aid market growth
10.2.4 NEUROLOGICAL DISORDERS
10.2.4.1 Growing target patient population and increasing research grants to fuel market growth
10.2.5 AUTOIMMUNE DISEASES
10.2.5.1 Increasing patient population and growing focus on immunology-based research to propel market growth
10.2.6 CARDIOVASCULAR DISEASES
10.2.6.1 High burden of cardiovascular diseases to spur adoption of reliable diagnostic tools
10.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS
10.3 DRUG DISCOVERY & DEVELOPMENT
10.3.1 TARGET DISCOVERY
10.3.1.1 Increased demand for personalized medicine to support segment growth
10.3.2 LEAD IDENTIFICATION
10.3.2.1 Lead identification to be essential in drug discovery and characterization
10.3.3 LEAD OPTIMIZATION
10.3.3.1 Need for optimizing drug efficacy and safety to spur segment growth
10.3.4 PRECLINICAL STUDIES
10.3.4.1 Integration of proteomics in preclinical studies to refine drug safety and efficacy
10.4 OTHER APPLICATIONS
11 PROTEOMICS MARKET, BY END USER
11.1 INTRODUCTION
11.2 BIOPHARMACEUTICAL COMPANIES
11.2.1 LOW OPERATING COSTS AND RAPID DRUG ANALYSIS TO DRIVE MARKET
11.3 ACADEMIC AND RESEARCH INSTITUTES
11.3.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINE TO BOOST MARKET GROWTH
11.4 HOSPITALS
11.4.1 GROWING PREVALENCE OF IMMUNODEFICIENCY DISEASES AND SERUM PROTEIN DISORDERS TO BOOST MARKET GROWTH
11.5 CLINICAL LABORATORIES
11.5.1 INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO SUPPORT MARKET GROWTH
11.6 OTHER END USERS
12 PROTEOMICS MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 US to dominate North American proteomics market during study period
12.2.3 CANADA
12.2.3.1 Favorable government initiatives and high incidence of cancer to support market growth
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Well-established pharmaceutical industry and increased government funding to augment market growth
12.3.3 UK
12.3.3.1 Developed life science industry and increased academia-industry partnerships to augment market growth
12.3.4 FRANCE
12.3.4.1 High investments in life science R&D and increased demand for personalized therapeutics to aid market growth
12.3.5 SWITZERLAND
12.3.5.1 Well-established pharmaceutical and biotechnology industry and increased investments in life science R&D to drive market
12.3.6 ITALY
12.3.6.1 High private and public R&D funding and favorable government initiatives to favor market growth
12.3.7 SPAIN
12.3.7.1 Well-established network of research centers, universities, and hospitals to aid market growth
12.3.8 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Rising government R&D investments and increasing focus on healthcare product manufacturing to fuel market growth
12.4.3 JAPAN
12.4.3.1 Large geriatric population and strong pharmaceutical research base to drive market
12.4.4 INDIA
12.4.4.1 Increasing focus on proteomics and genomic research to support market growth
12.4.5 SOUTH KOREA
12.4.5.1 Developed medical tourism and advanced healthcare infrastructure to propel market growth
12.4.6 AUSTRALIA
12.4.6.1 Favorable government initiatives and high R&D investments to favor market growth
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Increasing contract research and manufacturing activities to drive market
12.5.3 MEXICO
12.5.3.1 Strong pharmaceutical industry and increased government support to augment market growth
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
12.6.2 GCC COUNTRIES
12.6.2.1 Saudi Arabia
12.6.2.1.1 Increasing government healthcare investments and developing pharmaceuticals industry to boost market growth
12.6.2.2 UAE
12.6.2.2.1 High R&D expenditure and developed health infrastructure to drive market
12.6.2.3 Rest of GCC Countries
12.6.3 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 FAVORABLE GOVERNMENT INITIATIVES AND ADVANCEMENTS IN PERSONALIZED MEDICINES TO PROPEL MARKET GROWTH
12.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET
13.3 REVENUE ANALYSIS, 2021–2023
13.4 MARKET SHARE ANALYSIS, 2023
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Instrumentation technology footprint
13.5.5.3 Reagent footprint
13.5.5.4 Service footprint
13.5.5.5 Software footprint
13.5.5.6 Region footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 THERMO FISHER SCIENTIFIC INC.
14.1.1.1 Business overview
14.1.1.2 Products/Services/Solutions offered
14.1.2 RECENT DEVELOPMENTS
14.1.2.1 Product launches
14.1.2.2 Deals
14.1.2.3 MnM view
14.1.2.3.1 Key strengths
14.1.2.3.2 Strategic choices
14.1.2.3.3 Weaknesses and competitive threats
14.1.3 AGILENT TECHNOLOGIES, INC.
14.1.3.1 Business overview
14.1.3.2 Products/Services/Solutions offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.3.2 Deals
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 MERCK KGAA
14.1.4.1 Business overview
14.1.4.2 Products/Services/Solutions offered
14.1.4.3 MnM view
14.1.4.3.1 Key strengths
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses and competitive threats
14.1.5 DANAHER CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products/Services/Solutions offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.4 MnM view
14.1.5.4.1 Key strengths
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 SHIMADZU CORPORATION
14.1.6.1 Business overview
14.1.6.2 Products/Services/Solutions offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches
14.1.6.3.2 Expansions
14.1.6.4 MnM view
14.1.6.4.1 Key strengths
14.1.6.4.2 Strategic choices
14.1.6.4.3 Weaknesses and competitive threats
14.1.7 WATERS CORPORATION
14.1.7.1 Business overview
14.1.7.2 Products/Services/Solutions offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.8 BIO-RAD LABORATORIES, INC.
14.1.8.1 Business overview
14.1.8.2 Products/Services/Solutions offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.9 BRUKER
14.1.9.1 Business overview
14.1.9.2 Products/Services/Solutions offered
14.1.9.3 Recent developments
14.1.9.3.1 Product launches
14.1.9.3.2 Deals
14.1.10 REVVITY
14.1.10.1 Business overview
14.1.10.2 Products/Services/Solutions offered
14.1.10.3 Recent developments
14.1.10.3.1 Deals
14.1.11 ILLUMINA, INC.
14.1.11.1 Business overview
14.1.11.2 Products/Services/Solutions offered
14.1.11.3 Recent developments
14.1.11.3.1 Deals
14.1.12 PROMEGA CORPORATION
14.1.12.1 Business overview
14.1.12.2 Products/Services/Solutions offered
14.1.13 EUROFINS SCIENTIFIC
14.1.13.1 Business overview
14.1.13.2 Products/Services/Solutions offered
14.1.13.3 Recent developments
14.1.13.3.1 Deals
14.1.14 QIAGEN
14.1.14.1 Business overview
14.1.14.2 Products/Services/Solutions offered
14.1.14.3 Recent developments
14.1.14.3.1 Product launches
14.1.14.3.2 Deals
14.1.15 CHARLES RIVER LABORATORIES
14.1.15.1 Business overview
14.1.15.2 Products/Services/Solutions offered
14.1.15.3 Recent developments
14.1.15.3.1 Product launches
14.1.15.3.2 Deals
14.1.16 PROTAGENE
14.1.16.1 Business overview
14.1.16.2 Products/Services/Solutions offered
14.2 OTHER PLAYERS
14.2.1 CREATIVE PROTEOMICS, US
14.2.2 HORIBA JAPAN LTD.
14.2.3 SENGENICS CORPORATION LLC
14.2.4 LABVANTAGE-BIOMAX GMBH
14.2.5 FIOS GENOMICS
14.2.6 AZENTA US, INC.
14.2.7 MEDGENOME
14.2.8 BIOGNOSYS AG
14.2.9 MACROGEN, INC.
14.2.10 CELL SIGNALING TECHNOLOGY, INC.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
TABLE 1 PROTEOMICS MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 3 PROTEOMICS MARKET: RISK ANALYSIS
TABLE 4 INDICATIVE PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021–2023 (USD)
TABLE 5 PROTEOMICS PRODUCT AND SERVICE PROVIDERS: ROLE IN ECOSYSTEM
TABLE 6 END USERS: ROLE IN ECOSYSTEM
TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, JANUARY 2013–AUGUST 2024
TABLE 9 PROTEOMICS MARKET: TOP 10 PATENT OWNERS, 2013–2023
TABLE 10 KEY PATENTS IN PROTEOMICS MARKET, 2021–2024
TABLE 11 IMPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019–2023 (TON)
TABLE 12 EXPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019–2023 (TON)
TABLE 13 IMPORT VOLUME FOR MASS SPECTROMETERS (HS CODE: 902781),
2022–2023 (USD)
TABLE 14 EXPORT VOLUME FOR MASS SPECTROMETERS (HS CODE-902781),
2022–2023 (USD)
TABLE 15 PROTEOMICS MARKET: LIST OF KEY CONFERENCES AND EVENTS,
JANUARY 2024–DECEMBER 2025
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 PROTEOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES
TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE END USERS
TABLE 22 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 23 PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 24 PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION,
2022–2029 (USD MILLION)
TABLE 25 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 27 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 28 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 29 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 30 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 MASS SPECTROMETRY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 32 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 33 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 34 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 35 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 36 MIDDLE EAST: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 37 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 38 NMR SPECTROSCOPY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 39 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 40 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 41 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 42 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 43 MIDDLE EAST: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 44 GCC COUNTRIES: NMR SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 45 CD SPECTROSCOPY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 47 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 49 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 50 MIDDLE EAST: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 51 GCC COUNTRIES: CD SPECTROSCOPY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 52 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,
2022–2029 (USD MILLION)
TABLE 53 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION,
2022–2029 (USD MILLION)
TABLE 54 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 56 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 61 NORTH AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 EUROPE: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 ASIA PACIFIC: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 LATIN AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 MIDDLE EAST: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 GCC COUNTRIES: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ION CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 69 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 70 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 71 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 72 MIDDLE EAST: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 73 GCC COUNTRIES: ION CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 74 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 75 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 76 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 77 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 78 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 79 MIDDLE EAST: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 80 GCC COUNTRIES: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 81 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 MIDDLE EAST: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 GCC COUNTRIES: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,
2022–2029 (USD MILLION)
TABLE 89 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION,
2022–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 92 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 GEL ELECTROPHORESIS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 98 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 99 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 100 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 101 MIDDLE EAST: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 102 GCC COUNTRIES: GEL ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 103 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 104 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 105 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 106 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 107 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 108 MIDDLE EAST: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 109 GCC COUNTRIES: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 110 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,
2022–2029 (USD MILLION)
TABLE 111 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION,
2022–2029 (USD MILLION)
TABLE 112 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 119 BIOCHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 LATIN AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 MIDDLE EAST: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 GCC COUNTRIES: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 LAB-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 127 NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 128 EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 131 MIDDLE EAST: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 GCC COUNTRIES: LAB-ON-CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 133 PROTEIN CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 134 NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 135 EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 138 MIDDLE EAST: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 GCC COUNTRIES: PROTEIN CHIPS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 140 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 141 MICROARRAY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 142 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 143 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 144 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 145 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 146 MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 147 GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 148 INTEGRATED SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 150 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 151 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 152 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 153 MIDDLE EAST: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 154 GCC COUNTRIES: INTEGRATED SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 155 MICROARRAY SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 156 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 157 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 158 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 159 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 160 MIDDLE EAST: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 161 GCC COUNTRIES: MICROARRAY SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 162 ARRAYERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 163 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 MIDDLE EAST: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 GCC COUNTRIES: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION,
2022–2029 (USD MILLION)
TABLE 170 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 172 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION,
2022–2029 (USD MILLION)
TABLE 177 NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 MIDDLE EAST: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 GCC COUNTRIES: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION,
2022–2029 (USD MILLION)
TABLE 184 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES,
BY REGION, 2022–2029 (USD MILLION)
TABLE 191 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 EUROPE: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 193 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 PROTEOMICS MARKETS, BY REAGENT, 2022–2029 (USD MILLION)
TABLE 198 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 199 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 200 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 206 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 207 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 213 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 214 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 215 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 220 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 221 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 222 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 227 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 229 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 234 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 236 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 241 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 244 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 PROTEOMICS MARKET FOR OTHER REAGENTS, BY REGION,
2022–2029 (USD MILLION)
TABLE 248 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 250 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 251 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
TABLE 255 CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 256 CORE PROTEOMICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 257 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 258 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 259 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 260 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 261 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 262 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 263 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 264 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 265 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 266 ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 267 LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 MIDDLE EAST: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 269 GCC COUNTRIES: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 271 NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 272 EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 273 ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 275 MIDDLE EAST: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 276 GCC COUNTRIES: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 277 PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 278 NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 279 EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 280 ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281 LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2022–2029 (USD MILLION)
TABLE 282 MIDDLE EAST: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 283 GCC COUNTRIES: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 284 PROTEIN PURIFICATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 285 NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 286 EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 287 ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 288 LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 289 MIDDLE EAST: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 290 GCC COUNTRIES: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 291 PROTEIN SEPARATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 292 NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 293 EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 294 ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 295 LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 296 MIDDLE EAST: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 297 GCC COUNTRIES: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 298 PROTEIN SEQUENCING SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 299 NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 300 EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 301 ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 302 LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 303 MIDDLE EAST: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 304 GCC COUNTRIES: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 305 CUSTOM ASSAY SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 306 NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 307 EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 308 ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 309 LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 310 MIDDLE EAST: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 311 GCC COUNTRIES: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 312 BIOINFORMATICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 313 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 314 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 315 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 316 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 317 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 318 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 319 PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
TABLE 320 PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION,
2022–2029 (USD MILLION)
TABLE 321 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 322 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 323 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 324 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 325 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 326 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 327 PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY REGION,
2022–2029 (USD MILLION)
TABLE 328 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 329 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 330 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 331 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 332 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 333 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 334 PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 335 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2022–2029 (USD MILLION)
TABLE 336 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION,
2022–2029 (USD MILLION)
TABLE 337 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 338 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
Over the last decade, proteomics technology has been advancing steadily and has proven to be a powerful tool in the field of pharmaceutical drug discovery and development and in clinical diagnosis. It helps in detecting the disease in its nascent phase, predicting disease prognosis, and identifying druggable targets for new therapeutics. The proteomics market is divided into three major segments, namely instrumentation technology, reagents, and services. Factors such as innovations and development in instruments, extensive updation of old proteomics-based approaches, increasing research and development expenditures, and availability of funds from various organizations are driving the growth of the instrumentation technology and reagents markets. The services market is expected to register significant growth owing to the increase in proteomic outsourcing services to pharmaceutical and biotechnology companies, emergence of proteomics-specific analytical laboratories, and increasing utilization of bioinformatics tools in proteomics research. However, the economic downturn and lower adoption rates due to expensive tools and instruments are expected to restrict the growth of this market to a certain extent.
The global proteomics market is estimated to grow from $XX billion in 2013 to $XX billion by 2018, at a CAGR of XX%. The key players in the proteomics market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Life Technologies Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Danaher Corporation (AB Sciex and Beckman Coulter) (U.S.), Waters Corporation (U.S.), Roche (Switzerland), Bio-Rad Laboratories (U.S.), and Luminex Corporation (U.S.).
Currently, the global proteomics market is propelled by the increasing demand for personalized medicine, rising research and development expenditures, technological advancements, and increased funding for proteomics projects. This increase in demand can be attributed to the development of proteomic tools for the early detection of cancer and rising healthcare awareness across the world. The deployment of proteomic-based approaches in the biomarker detection and cancer profiling is expected to play a vital role in the growth of the market during the forecast period. In addition, the rising potential for proteomics to move beyond basic research, into clinical research and diagnostics, is expected to drive the proteomics market during the forecast period.
In terms of geographic focus, the market has moved from the developed markets across North America and Europe to the high-growth developing markets across Asia especially the Chinese region. The increasing outsourcing trend in the pharmaceutical industry has also led to a surge in the proteomics market across India and China. China has emerged as the preferred R&D location for global pharmaceutical companies. Moreover, Japan has also emphasized on increasing the R&D expenditure in the country; indicating gradual development of a strong research base in the Asia-Pacific region, which in turn will drive the market for proteomics research and its application in this region.
The global proteomics market studied in this report is segmented in three ways, namely, by instrumentation technology, by reagents and by services type. The instrumentation technology segment is further classified as protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, surface plasmon resonance (SPR) system, and protein fractionation system.
